Hologic Inc (HOLX) - Financial and Strategic SWOT Analysis Review
The profile contains critical company information including:
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Hologic Inc (Hologic) develops, manufactures and supplies diagnostic products, medical imaging systems, and surgical products. It offers products to aid in the diagnosis of human diseases; breast imaging and related products and accessories; gyn surgical products including endometrial ablation system and hysteroscopic tissue removal system; and skeletal health products including dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company offers these solutions to surgeons, hospitals, clinical laboratories, and healthcare providers. Hologic offers its products and services through direct sales and a network of independent distributors and sales representatives. The company operates in the Americas, Europe, and Asia-Pacific. Hologic is headquartered in Marlborough, Massachusetts, the US.
Hologic Inc Key Recent Developments
Mar 02,2021: Hologic acquires diagnostic assays manufacturer Diagenode for $159m
Mar 01,2021: Hologic Acquires European Molecular Diagnostic Company Diagenode for Approximately $159 Million
Feb 10,2021: Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences
Jan 27,2021: Hologic announces financial results for first quarter of fiscal 2021
Jan 08,2021: Hologic announces preliminary financial results for first quarter of fiscal 2021
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
List of Tables
List of Figures
Section 1 - About the Company
Hologic Inc - Key Facts
Hologic Inc - Key Employees
Hologic Inc - Key Employee Biographies
Hologic Inc - Major Products and Services
Hologic Inc - History
Hologic Inc - Company Statement
Hologic Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Section 2 Company Analysis
Company Overview
Hologic Inc - Business Description
Business Segment: Breast Health
Overview
Performance
Business Segment: Diagnostics
Overview
Performance
Business Segment: GYN Surgical
Overview
Performance
Business Segment: Medical Aesthetics
Overview
Performance
Business Segment: Skeletal Health
Overview
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: The US
Performance
R&D Overview
Hologic Inc - Corporate Strategy
Hologic Inc - SWOT Analysis
SWOT Analysis - Overview
Hologic Inc - Strengths
Hologic Inc - Weaknesses
Hologic Inc - Opportunities
Hologic Inc - Threats
Hologic Inc - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
Hologic Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Hologic Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Hologic Inc, Recent Deals Summary
Section 5 Companys Recent Developments
Mar 02, 2021: Hologic acquires diagnostic assays manufacturer Diagenode for $159m
Feb 10, 2021: Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences
Jan 27, 2021: Hologic announces financial results for first quarter of fiscal 2021
Jan 08, 2021: Hologic announces preliminary financial results for first quarter of fiscal 2021
Nov 27, 2020: Hologic to showcase products across breast cancer screening, biopsy, surgery and treatment at virtual RSNA 2020
Nov 04, 2020: Hologic announces financial results for fourth quarter of fiscal 2020
Oct 06, 2020: HOLOGIC: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Sep 14, 2020: Hologic announces offering of $950 million of senior notes due 2029
Aug 26, 2020: Hologic acquires fibroids treatment solution developer Acessa Health
Aug 06, 2020: RadNet and Hologic announce collaboration to advance the development of artificial intelligence tools in breast health
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List Of Tables
Hologic Inc, Key Facts
Hologic Inc, Key Employees
Hologic Inc, Key Employee Biographies
Hologic Inc, Major Products and Services
Hologic Inc, History
Hologic Inc, Other Locations
Hologic Inc, Subsidiaries
Hologic Inc, Affiliate
Hologic Inc, Key Competitors
Hologic Inc, Ratios based on current share price
Hologic Inc, Annual Ratios
Hologic Inc, Annual Ratios (Cont...1)
Hologic Inc, Annual Ratios (Cont...2)
Hologic Inc, Interim Ratios
Hologic Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Hologic Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Hologic Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List Of Figures
Hologic Inc, Performance Chart (2016 - 2020)
Hologic Inc, Ratio Charts
Hologic Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Hologic Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021
Hologic Full Year Operating Financial
Hologic 2023 Full Year Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Diagnostic Imaging Industry This report is part of the
USD 750 View ReportHologic 2023 Third Quarter Operating and Financial Review
Hologic 2023 Third Quarter Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Diagnostic Imaging Industry This report is part of the Competitive
USD 750 View ReportHologic Inc (HOLX) - Product Pipeline Analysis, 2020 Update
Hologic Inc (Hologic) develops, manufactures and supplies diagnostic products, medical imaging systems, and surgical products. It offers products to aid in the diagnosis of human diseases; breast imaging and related
USD 750 View ReportHologic Inc (HOLX) - Product Pipeline Analysis, 2019 Update
Hologic Inc (Hologic) develops, manufactures and supplies diagnostic products, medical imaging systems, surgical products and light-based aesthetic and medical treatment systems. The company offers products to aid in the diagnosis
USD 750 View ReportFill The Form For Sample Request